Incidence of clinical tumour lysis syndrome · children with haematological malignancy at risk of tumour lysis syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality due to tumour lysis syndrome · children with haematological malignancy at risk of tumour lysis syndrome
1 finding from 1 review
Overall survival (reported as mortality) · high‐risk neuroblastoma patients treated with autologous HSCT
Retinoic acid postconsolidation therapy showed no clear difference in overall survival (reported as mortality) compared with no further treatment (low certainty).
1 finding from 1 review
Treatment‐related mortality ‐ not reported · high‐risk neuroblastoma patients treated with autologous HSCT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Progression‐free survival ‐ not reported · high‐risk neuroblastoma patients treated with autologous HSCT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Event‐free survival · high‐risk neuroblastoma patients treated with autologous HSCT
Retinoic acid postconsolidation therapy showed no clear difference in event‐free survival (reported as relapse, disease progression, death… compared with no further treatment (low certainty).
1 finding from 1 review
Early toxicity ‐ not reported · high‐risk neuroblastoma patients treated with autologous HSCT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Late toxicity including secondary malignancies ‐ not reported · high‐risk neuroblastoma patients treated with autologous HSCT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life ‐ not reported · high‐risk neuroblastoma patients treated with autologous HSCT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment failure; rehospitalization or adjustment of antimicrobial treatment (or both) in number of episodes · children with cancer
Early discharge showed no clear difference in treatment failure; rehospitalization or adjustment of antimicrobial… compared with non‐early discharge (low certainty).
1 finding from 1 review
RR 0.91 [0.24, 3.5]
Studies not reported
Low
Treatment failure; death · children with cancer
Very early discharge may leads to lower treatment failure; death compared with early discharge (low certainty).
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Costs · children with cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Duration of total antimicrobial treatment · children with cancer
Very early discharge may leads to lower duration of total antimicrobial treatment compared with early discharge (low certainty).
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Duration of intravenous antimicrobial treatment · children with cancer
Very early discharge may leads to lower duration of intravenous antimicrobial treatment compared with early discharge (low certainty).
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Duration of oral antimicrobial treatment · children with cancer
Very early discharge may leads to lower duration of oral antimicrobial treatment compared with early discharge (low certainty).
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Quality of life · children with cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment failure; death · children with cancer
Early discharge may leads to lower treatment failure; death compared with non‐early discharge (low certainty).
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Costs · children with cancer
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Duration of total antimicrobial treatment · children with cancer
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Duration of intravenous antimicrobial treatment · children with cancer
1 finding from 1 review
no estimate extracted
Studies not reported
Low